In addition, these results substantiate our previous in vitro data that cell death induction after treatment with C6-ceramide nanoliposomes involves targeting of GAPDH and the glycolytic pathway in CLL. Here, GAPDH is linked to B-cell chronic lymphocytic leukemia.